Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for prevention of postoperative orthostatic intolerance after hip or knee arthroplasty
ACTRN12620001342909Phase 3Completed
- Sponsor
- Waitematā District Health Board
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in orthostatic intolerance and orthostatic hypotension (OH) comparing Midodrine with Placebo (2 arms). Primary endpoint: Incidence of orthostatic intolerance during first mobilisation after surgery. Started Jan 2021; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic intoleranceorthostatic hypotension (OH)
Beyond the preview
Go deeper on ACTRN12620001342909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001342909.